H-Y antibody development associates with acute rejection in female patients with male kidney transplants - Wikidata - thesis-toulmin - TriplyDB

H-Y antibody development associates with acute rejection in female patients with male kidney transplants

H-Y antibody development associates with acute rejection in female patients with male kidney transplants

http://www.wikidata.org/entity/Q34147590

about

Biologics in renal transplantation Sex matters, but to what clinical avail?H-Y Antigen Incompatibility Not Associated with Adverse Immunologic Graft Outcomes: Deceased Donor Pair Analysis of the OPTN Database Human and murine kidneys show gender- and species-specific gene expression differences in response to injury Donor-recipient gender and size mismatch affects graft success after kidney transplantation.H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.Gender differences in liver donor quality are predictive of graft loss Clinical impact of H-Y alloimmunity Cardiac allograft vasculopathy: a donor or recipient induced pathology?Recent advances in renal transplantation: antibody-mediated rejection takes center stage Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.Donor-recipient sex mismatch in kidney transplantation Decay accelerating factor is essential for successful corneal engraftment Alemtuzumab induction in pediatric kidney transplantation.Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts.H-Y incompatibility predicts short-term outcomes for kidney transplant recipients Current status of immunosuppressive agents for solid organ transplantation in children.Steroid withdrawal in renal transplantation.A systems-based approach to managing blood pressure in children following kidney transplantation.Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction.Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation.Association of Sex with Risk of Kidney Graft Failure Differs by Age.Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience.Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.Applying Genomics in Heart Transplantation.Alemtuzumab induction in pediatric kidney transplantation.Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients.

P2860

Q27009997-D30A5CAD-BAD1-4CC6-BC65-0959924FBB19 Q28748739-CCC2F165-49B2-46CD-8B39-A7F1ED3EE67C Q30430243-FCEE8DA0-1D8E-47F2-80E5-7B5822289553 Q33416779-0F8DF8A4-5130-42BF-B3B3-48A29A27B270 Q33920683-DEC84A0C-AF7F-4521-AFEE-1E5B58F3B566 Q34202524-B66F825D-22F7-4BAE-B439-C80F8E569623 Q34792728-E34B793A-3747-4DBF-A717-46F4A0B8A281 Q35235186-D7461619-F200-4231-B20B-AF5ECC9C5DBB Q35244151-8D3482D0-D0B6-49F2-85D4-87C68F125F83 Q35659332-44137436-8E03-4B92-9E6D-F6899E224CD1 Q35811966-61A5572E-6A4A-4EA4-913A-E02E84E40F87 Q36338297-BCC62F48-E8F6-44F4-B43C-3D9BF7678D8A Q36461741-18FE9461-A86E-4A16-8D51-7E9F284C735E Q36818003-9A116C6D-E352-4CE1-A9E5-72BDC63DFB80 Q37086379-174D9E2C-8427-4934-8A71-E9EE5921E8BC Q37330552-A32E4C96-2B5D-4964-A7C2-E7E551E0703C Q37987565-20A325E5-398B-48D6-8DE4-B924A7CA5CF0 Q38071546-8E0B4CFA-258D-4FE6-83C2-F7F771178DE3 Q38611402-82B099F0-01F9-42B7-8017-39DD270FF65C Q39363717-4151C05A-8FED-4872-AF34-882A7F79FDB0 Q39409394-50E4A5AE-3FAE-4229-AA5F-C06E7BAA2AA0 Q40168444-30D0001C-79BD-439E-98DE-8B932B382890 Q42226145-2C50F3E5-D167-4967-9CF1-10C92D8DA866 Q48664001-D2105291-887A-4176-ABCE-AB3BCF4F320B Q49834046-84A60C3D-2D5E-49C2-A8C6-E0B5BD2B9EAE Q51071488-9BB45466-FBD7-44F2-BDA3-B555D57577D3 Q54687845-840BD0DB-EB43-4B54-9BB0-13764A320071

P2860

H-Y antibody development associates with acute rejection in female patients with male kidney transplants

http://www.wikidata.org/entity/Q34147590

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

H-Y antibody development assoc ...... s with male kidney transplants

@ast

H-Y antibody development assoc ...... s with male kidney transplants

@en

H-Y antibody development assoc ...... s with male kidney transplants

@nl

type

label

H-Y antibody development assoc ...... s with male kidney transplants

@ast

H-Y antibody development assoc ...... s with male kidney transplants

@en

H-Y antibody development assoc ...... s with male kidney transplants

@nl

prefLabel

H-Y antibody development assoc ...... s with male kidney transplants

@ast

H-Y antibody development assoc ...... s with male kidney transplants

@en

H-Y antibody development assoc ...... s with male kidney transplants

@nl

P1433

Q34147590-05B7E8D2-DA22-4DF6-ADEA-FB182B1BCEFB

P1476

Q34147590-0004EB60-114A-4225-A0B6-D8EC2E868708

P2093

Q34147590-2358A44F-B7A5-46CD-AC0C-25183875FF22

Q34147590-5970CCD3-42D9-428D-95D7-0200E48680F0

Q34147590-7CEFF1D3-30B4-4393-9624-41C09E8A245F

Q34147590-7D97A640-7AA3-47BB-820F-275C38A6CA9C

Q34147590-8F078B28-5397-467A-875C-75FBC869F6F8

Q34147590-A9CF98A4-8EBC-4617-A910-54123FDAA5AE

Q34147590-AE16E60A-4A5C-4F99-B812-A32F1BE29965

Q34147590-E11BCB2F-0B85-4484-A6F9-F23AE4BDB4ED

Q34147590-E2367203-5F8B-4602-AC45-C2564D848453

P2860

Q34147590-111A60B5-DC4E-4BCF-A68C-67F169D3A1BD

Q34147590-1F1C3865-BB28-4326-9A2E-247F628ACC4F

Q34147590-227C8F4A-2AA8-42D6-AEFF-4192E7345D91

Q34147590-2A4AB625-D814-4561-B8A3-73B6E3FC527C

Q34147590-3A5AE6DA-106C-4D06-BA43-F1524E1665F9

Q34147590-3B79A149-AC8D-4B17-A419-BB152D9C0499

Q34147590-4C1999C1-6071-4614-BD26-3F6DA95846D0

Q34147590-5951FB1C-A83F-4088-9D7B-7742D9835411

Q34147590-61FE3AC0-6661-46AF-9512-BF371ED01CF1

Q34147590-6C1CBAE9-767D-41C7-8A5A-E068D2401033

P304

Q34147590-DA587E0A-7E1F-4ADD-BCF7-CBF7339B5997

P31

Q34147590-47950341-D8F1-4963-88F2-D35BF3811AB3

P356

Q34147590-02B52853-3B79-427D-8ADD-193198BE8056

P433

Q34147590-51C0ACBE-B3FF-42CA-980F-31D58816AC66

P478

Q34147590-ABD194AC-CAE4-4515-B039-CF6D74D57C8E

P577

Q34147590-EA4873C5-EE35-4F36-BE3C-B345CEFFF2D5

P698

Q34147590-8609CD4B-DEA5-407A-9C44-9F6F85546B5E

Q34147590-fb85b2cf-f0d3-48c9-933a-dcbe45d26625

P921

Q34147590-C9619684-054D-4348-8A2A-77E192FF0279

P932

Q34147590-2C9BE6C4-5A48-4435-9BBC-BFB779980134

P356

TP.0B013E3181903DA7

P1433

Transplantation

P1476

H-Y antibody development assoc ...... s with male kidney transplants

@en

P2093

David B Miklos

http://www.w3.org/2001/XMLSchema#string

F Carl Grumet

http://www.w3.org/2001/XMLSchema#string

Jane C Tan

http://www.w3.org/2001/XMLSchema#string

Katherine Miller

http://www.w3.org/2001/XMLSchema#string

Marc Coram

http://www.w3.org/2001/XMLSchema#string

Neeraja Kambham

http://www.w3.org/2001/XMLSchema#string

Persis P Wadia

http://www.w3.org/2001/XMLSchema#string

Shalini Pereira

http://www.w3.org/2001/XMLSchema#string

Tamara Vayntrub

http://www.w3.org/2001/XMLSchema#string

P2860

Functional coherence of the human Y chromosome

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.

Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data.

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

The UTX gene escapes X inactivation in mice and humans.

Humoral theory of transplantation.

Y-antigen killing by T cells of women is restricted by HLA.

Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.

P304

75-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3181903DA7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18622281

http://www.w3.org/2001/XMLSchema#string

P921

P932

2943873

http://www.w3.org/2001/XMLSchema#string